KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Asset Utilization Ratio (2019 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Asset Utilization Ratio for 7 consecutive years, with 0.55 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 69.36% to 0.55 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.55 through Dec 2025, up 69.36% year-over-year, with the annual reading at 0.53 for FY2025, 76.6% up from the prior year.
  • Asset Utilization Ratio hit 0.55 in Q4 2025 for Adaptive Biotechnologies, up from 0.51 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.55 in Q4 2025 to a low of 0.11 in Q1 2021.
  • Historically, Asset Utilization Ratio has averaged 0.25 across 5 years, with a median of 0.2 in 2022.
  • Biggest five-year swings in Asset Utilization Ratio: skyrocketed 81.11% in 2021 and later decreased 12.07% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.16 in 2021, then surged by 32.14% to 0.21 in 2022, then fell by 12.07% to 0.19 in 2023, then surged by 74.16% to 0.33 in 2024, then surged by 69.36% to 0.55 in 2025.
  • Business Quant data shows Asset Utilization Ratio for ADPT at 0.55 in Q4 2025, 0.51 in Q3 2025, and 0.41 in Q2 2025.